Sales revenues for Octomber 2012

The Board of Directors of Sopharma AD (the “Company”) notifies that for October 2012 Sopharma AD realized decrease of sales revenues of 2% compared to the same period of 2011, including 10% decrease of domestic sales and 2% increase of export sales.

During the first ten months of this year Sopharma AD realized an increase of sales revenues of 2%, including 10% decrease of domestic sales and 7% increase of export sales compared to the same period of 2011.